Naperville, IL -- (SBWIRE) -- 10/10/2012 -- Summary
Thermo Fisher to Acquire One Lambda - A Move to Complement its Specialty Diagnostics Segment provides key insights on the deal. The report has comprehensive analysis of the strategic rationale behind the deal. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
- Deal overview on the acquisition of One Lambda by Thermo Fisher.
- Strategic rationale behind the deal including analysis of the impact of the deal on the industry and on both the companies.
- Company profiles of One Lambda and Thermo Fisher.
Reasons to buy
- Understand the strategy behind the deal.
- Explore trends and dynamics in the In Vitro Diagnostics (IVD) market.
To view table of contents for this market report please visit: